Catalyst Wire Dossier Catalyst Wire Dossier

Cross-linked hyaluronic acid/dextranomer

dextranomer in hyaluronic acid (cross-linked)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cross-linked hyaluronic acid/dextranomer, covering 2024-09-26 to 2024-09-26. Get the full timeline:

Most recent: Clinical Trial Update: Cross-linked Hyaluronic Acid/dextranomer for the Treatment of Stress Urinary Incontinence [Phase 2]

See pricing